Analysis of vascular endothelial growth factor (VEGF) functional variants in rheumatoid arthritis

29Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The vascular endothelial growth factor (VEGF) is one of the most important pro-angiogenic mediators related to inflammation-associated synovial angiogenesis. The aim of this study was to asses the role of -1154 G→A (rs1570360) and -634 G→C (rs2010963) VEGF gene functional variants with rheumatoid arthritis (RA). The population under study was composed of a total of 753 unrelated RA patients and 801 healthy controls. The VEGF -1154 G→A and -634 G→C polymorphism genotyping was performed by real-time polymerase chain reaction technology, using TaqMan 5′ allelic discrimination assay. No evidence of association was observed between the -1154 G→A and the -634 G→C VEGF polymorphisms, or inferred VEGF haplotypes with RA susceptibility or clinical manifestations. Our results suggest that the analyzed VEGF promoter polymorphisms may not play a relevant role in RA pathogenesis in our population. © American Society for Histocompatibility and Immunogenetics, 2005. Published by Elsevier Inc.

Cite

CITATION STYLE

APA

Rueda, B., González-Gay, M. Á., López-Nevot, M. Á., García, A., Fernández-Arquero, M., Balsa, A., … Martín, J. (2005). Analysis of vascular endothelial growth factor (VEGF) functional variants in rheumatoid arthritis. Human Immunology, 66(8), 864–868. https://doi.org/10.1016/j.humimm.2005.05.004

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free